Avista Public Acquisition Corp. II Contracts & Agreements
67 Contracts & Agreements
- Business Finance (29 contracts)
- Business Operations (4)
- Human Resources (16)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (14)
- OmniAb, Inc. Director Compensation and Stock Ownership Policy (as amended and restated effective June 1, 2023) (Filed With SEC on August 10, 2023)
- Assignment of Lease, Consent to Assignment of Lease and First Amendment to Lease, dated for reference purposes only as of October 26, 2022, by Emery Station Office II, LLC, Ligand... (Filed With SEC on March 30, 2023)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Charles S. Berkman (Filed With SEC on March 30, 2023)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Kurt A. Gustafson (Filed With SEC on March 30, 2023)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Matthew W. Foehr (Filed With SEC on March 30, 2023)
- OmniAb, Inc. Director Compensation and Stock Ownership Policy (as amended and restated effective February 3, 2023) (Filed With SEC on March 30, 2023)
- Description of Registered Securities (Filed With SEC on March 30, 2023)
- OmniAb, Inc. Severance Plan (Filed With SEC on November 7, 2022)
- Tax Matters Agreement, dated November 1, 2022, by and among OmniAb, Inc., Ligand Pharmaceuticals Incorporated and OmniAb Operations, Inc (Filed With SEC on November 7, 2022)
- OmniAb, Inc. Director Compensation and Stock Ownership Policy (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 OmniAb Service Provider Assumed Award Plan (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 Ligand Service Provider Assumed Award Plan (Filed With SEC on November 7, 2022)
- Form of Performance Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Restricted Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Stock Option Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by OmniAb, Inc. to Ligand... (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by Ligand Pharmaceuticals... (Filed With SEC on November 7, 2022)
- Tax Matters Agreement, dated November 1, 2022, by and among OmniAb, Inc., Ligand Pharmaceuticals Incorporated and OmniAb Operations, Inc (Filed With SEC on November 7, 2022)
- Amended and Restated Registration and Stockholder Rights Agreement, dated November 1, 2022 by and among OmniAb, Inc., Avista Acquisition LP II and the other parties named therein (Filed With SEC on November 7, 2022)
- Assignment, Assumption and Amendment Agreement, dated November 1, 2022, by and among OmniAb, Inc., Continental Stock Transfer & Trust Company and Computershare Trust Company, N.A (Filed With SEC on November 7, 2022)
- Assignment, Assumption and Amendment Agreement, dated November 1, 2022, by and among OmniAb, Inc., Continental Stock Transfer & Trust Company and Computershare Trust Company, N.A (Filed With SEC on November 7, 2022)
- Amended and Restated Registration and Stockholder Rights Agreement, dated November 1, 2022 by and among OmniAb, Inc., Avista Acquisition LP II and the other parties named therein (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by Ligand Pharmaceuticals... (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by OmniAb, Inc. to Ligand... (Filed With SEC on November 7, 2022)
- Form of Stock Option Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Restricted Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Performance Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 Ligand Service Provider Assumed Award Plan (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 OmniAb Service Provider Assumed Award Plan (Filed With SEC on November 7, 2022)
- OmniAb, Inc. Director Compensation and Stock Ownership Policy (Filed With SEC on November 7, 2022)
- OmniAb, Inc. Severance Plan (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on October 24, 2022)
- OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on October 24, 2022)
- Amended and Restated License Agreement between F. Hoffmann-La Roche Ltd, Hoffmann-La Roche lnc. and Icagen, LLC, dated May 29, 2020, as amended (Filed With SEC on April 28, 2022)
- Research, Development and Commercialization Agreement between Cystic Fibrosis Foundation and Icagen, LLC, dated May 1, 2018, as amended (Filed With SEC on April 28, 2022)
- Antibody License Agreement between CNA Development LLC and OmniAb, Inc., dated December 20, 2012 (Filed With SEC on April 28, 2022)
- Lab Lease Between Emery Station Office II, LLC and Crystal Bioscience, Inc., dated February 16, 2009, as amended (Filed With SEC on April 28, 2022)
- Form of OmniAb, Inc. Indemnification Agreement for Directors and Officers (Filed With SEC on April 28, 2022)
- Description of Securities (Filed With SEC on March 28, 2022)
- Promissory Note, dated March 14, 2022, issued by Avista Public Acquisition Corp. II to Avista Acquisition LP II (Filed With SEC on March 14, 2022)
- Form of Letter Agreements, dated August 9, 2021, between the Company and each of its officers and directors and the Sponsor (Filed With SEC on August 12, 2021)
- Warrant Agreement, dated August 9, 2021, between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on August 12, 2021)
- Investment Management Trust Agreement, dated August 9, 2021, between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on August 12, 2021)
- Registration Rights Agreement, dated August 9, 2021, among the Company, the Sponsor and certain other security holders named therein (Filed With SEC on August 12, 2021)
- Private Placement Warrants Purchase Agreement, dated August 9, 2021, between the Company and the Sponsor (Filed With SEC on August 12, 2021)
- Administrative Services Agreement, dated August 9, 2021, between the Company and an affiliate of the Sponsor (Filed With SEC on August 12, 2021)
- Form of Indemnity Agreements, dated August 9, 2021, between the Company and each of its officers and directors and the Sponsor (Filed With SEC on August 12, 2021)
- Forward Purchase Agreement, dated August 9, 2021, between the Company and the Sponsor (Filed With SEC on August 12, 2021)
- Form of Letter Agreement between the Registrant, the Sponsor and each director and executive officer of the Registrant (Filed With SEC on July 28, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 28, 2021)
- Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on July 28, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on July 28, 2021)
- Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on July 28, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on July 28, 2021)
- Form of Forward Purchase Agreement (Filed With SEC on July 28, 2021)
- Specimen Unit Certificate (Filed With SEC on June 17, 2021)
- Form of Forward Purchase Agreement (Filed With SEC on June 17, 2021)
- Form of Letter Agreement between the Registrant, the Sponsor and each director and executive officer of the Registrant (Filed With SEC on June 17, 2021)
- Securities Subscription Agreement, dated February 12, 2021, between the Registrant and the Sponsor (Filed With SEC on June 17, 2021)
- Promissory Note, dated as of February 12, 2021, between the Registrant and the Sponsor (Filed With SEC on June 17, 2021)
- Form of Administrative Services Agreement between the Registrant and the Sponsor (Filed With SEC on June 17, 2021)
- Form of Indemnity Agreement (Filed With SEC on June 17, 2021)
- Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on June 17, 2021)
- Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on June 17, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on June 17, 2021)
- Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on June 17, 2021)
- Specimen Class A Ordinary Share Certificate (Filed With SEC on June 17, 2021)
